We at Valisure have been appreciative of our association with Congressman Rosa DeLauro over the years. Rosa DeLauro is the Congresswoman from Connecticut’s Third Congressional District and strongly believes in the power of biomedical research and is working to increase funding to make lifesaving breakthroughs in science and medicine.

Rosa DeLauro has similar values to the Valisure mission. She has relentlessly advocated for the Recall Unsafe Drugs Act, which would enable the FDA to step in and issue a mandatory recall of products that have been found to cause serious health consequences or death. As we have seen in our research, this problem extended to popular drugs like Zantac.

On December 18, 2019, Rosa DeLauro and David Light wrote a letter to FDA Commissioner Stephen Hahn and the Department of Health and Human Services (HHS) Secretary Alex Azar to recall drugs containing ranitidine due to high levels of N-Nitrososdimethylamine (“NDMA”), a probable human carcinogen. A signed copy of the letter can be found here.

On January 10, 2020, Rosa DeLauro, alongside David Light, Joe Graedon (Pharmacologist and Co-Host of The People’s Pharmacy on NPR), and Dr. Jon Ernstoff (Gastroenterologist at MidState Medical Center in Connecticut), participated in a news conference to reiterate the call to ban sales of ranitidine—the active ingredient in Zantac—and reintroduced the Recall Unsafe Drugs Act.

On September 28, 2021, Rosa DeLauro participated in Joe Graedon’s webinar announced via The People’s Pharmacy. David Light spoke to the research at Valisure that uncovered the contamination in several drugs and consumer products. Other participants included Dr. James Arbogast (Chief Scientist at GOJO Industries, makers of Purell hand sanitizer) and Dr. Christopher Bunick (Associate Professor of Dermatology at Yale University).

On February 4, 2022, Rosa DeLauro celebrated the inclusion of a provision in America COMPETES Act to give the FDA mandatory recall authority over drug products. In a press release announced through the DeLauro team, David Light commented, “At Valisure, we applaud Congresswoman Rosa DeLauro for tirelessly advocating for the FDA to acquire mandatory recall authority over drugs and, ultimately, add this matter to the COMPETES Act. We strongly support efforts to improve the quality of the U.S. drug supply, which is heavily reliant on a complex, global, and increasingly vulnerable supply chain. We hope the FDA will utilize its new authority in conjunction with the proven impact of independent testing, identifying multiple adulterated products, and industry-wide quality concerns. Increased vigilance and independent quality assurance throughout the supply chain with enhanced regulatory authority can significantly diminish the unnecessary risk to consumers from contaminated or otherwise adulterated products. We encourage the FDA and Congress to continue taking actions to improve drug quality and the robustness of the global supply chain.”

Most recently, on February 24, 2022, Rosa DeLauro joined David Light in speaking with CBS’ The Doctors regarding his concerns about finding benzene in multiple consumer products. It is classified as a group 1 carcinogen and known to cause cancer in humans. Congressman Rosa DeLauro joined David and encouraged consumers to contact their elected officials to express their concerns and pass a bill giving the FDA power to recall unsafe drugs.

‍

We at Valisure have been appreciative of our association with Congressman Rosa DeLauro over the years. Rosa DeLauro is the Congresswoman from Connecticut’s Third Congressional District and strongly believes in the power of biomedical research and is working to increase funding to make lifesaving breakthroughs in science and medicine.

Rosa DeLauro has similar values to the Valisure mission. She has relentlessly advocated for the Recall Unsafe Drugs Act, which would enable the FDA to step in and issue a mandatory recall of products that have been found to cause serious health consequences or death. As we have seen in our research, this problem extended to popular drugs like Zantac.

On December 18, 2019, Rosa DeLauro and David Light wrote a letter to FDA Commissioner Stephen Hahn and the Department of Health and Human Services (HHS) Secretary Alex Azar to recall drugs containing ranitidine due to high levels of N-Nitrososdimethylamine (“NDMA”), a probable human carcinogen. A signed copy of the letter can be found here.

On January 10, 2020, Rosa DeLauro, alongside David Light, Joe Graedon (Pharmacologist and Co-Host of The People’s Pharmacy on NPR), and Dr. Jon Ernstoff (Gastroenterologist at MidState Medical Center in Connecticut), participated in a news conference to reiterate the call to ban sales of ranitidine—the active ingredient in Zantac—and reintroduced the Recall Unsafe Drugs Act.

On September 28, 2021, Rosa DeLauro participated in Joe Graedon’s webinar announced via The People’s Pharmacy. David Light spoke to the research at Valisure that uncovered the contamination in several drugs and consumer products. Other participants included Dr. James Arbogast (Chief Scientist at GOJO Industries, makers of Purell hand sanitizer) and Dr. Christopher Bunick (Associate Professor of Dermatology at Yale University).

On February 4, 2022, Rosa DeLauro celebrated the inclusion of a provision in America COMPETES Act to give the FDA mandatory recall authority over drug products. In a press release announced through the DeLauro team, David Light commented, “At Valisure, we applaud Congresswoman Rosa DeLauro for tirelessly advocating for the FDA to acquire mandatory recall authority over drugs and, ultimately, add this matter to the COMPETES Act. We strongly support efforts to improve the quality of the U.S. drug supply, which is heavily reliant on a complex, global, and increasingly vulnerable supply chain. We hope the FDA will utilize its new authority in conjunction with the proven impact of independent testing, identifying multiple adulterated products, and industry-wide quality concerns. Increased vigilance and independent quality assurance throughout the supply chain with enhanced regulatory authority can significantly diminish the unnecessary risk to consumers from contaminated or otherwise adulterated products. We encourage the FDA and Congress to continue taking actions to improve drug quality and the robustness of the global supply chain.”

Most recently, on February 24, 2022, Rosa DeLauro joined David Light in speaking with CBS’ The Doctors regarding his concerns about finding benzene in multiple consumer products. It is classified as a group 1 carcinogen and known to cause cancer in humans. Congressman Rosa DeLauro joined David and encouraged consumers to contact their elected officials to express their concerns and pass a bill giving the FDA power to recall unsafe drugs.

‍